Makoto Ueno
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 5
- Cardiac Structural Anomalies and Repair 2
-
- Oral and gingival health research 3
-
- Rheumatoid Arthritis Research and Therapies 3
-
- Stroke Rehabilitation and Recovery 2
-
- Cardiac Imaging and Diagnostics 2
-
- Pancreatic and Hepatic Oncology Research 2
- Peptidase Inhibition and Analysis 2
- Co-authors
- Hiroaki SakuraiTakahisa SugitaMasaki SugiuraYutaka HisadaIsao TakataKazunori ImaizumiSatoshi KobayashiTaito Fukushima
- Journals
- Journal of Clinical Oncology (5 papers)Journal of Neuroscience (1 paper)Journal of the American College of Cardiology (2 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Makoto Ueno
26 papers receiving 425 citations
Peers
Comparison fields: 5 of 87
- Immunology 97
- Immunology and Allergy 26
- Nephrology 26
- Cardiology and Cardiovascular Medicine 70
- Cancer Research 40
Countries citing papers authored by Makoto Ueno
This map shows the geographic impact of Makoto Ueno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makoto Ueno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makoto Ueno more than expected).
Fields of papers citing papers by Makoto Ueno
This network shows the impact of papers produced by Makoto Ueno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makoto Ueno. The network helps show where Makoto Ueno may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Makoto Ueno, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 20 | |
| 4 | 2024 | 13 | |
| 5 | 2023 | 1 | |
| 6 | 2022 | 5 | |
| 7 | 2019 | 9 | |
| 8 | 2015 | 20 | |
| 9 | 2014 | 2 | |
| 10 | 2012 | 2 | |
| 11 | 2011 | 2 | |
| 12 | 2011 | 0 | |
| 13 | 2007 | 64 | |
| 14 | 2003 | 6 | |
| 15 | 1998 | 27 | |
| 16 | 1996 | 113 | |
| 17 | 1995 | 60 | |
| 18 | 1994 | 38 | |
| 19 | 1994 | 27 | |
| 20 | 1990 | 4 |
About Makoto Ueno
Makoto Ueno is a scholar working on Pharmacy, Immunology and Allergy and Rehabilitation, having authored 28 papers that have together received 443 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (5 papers), Oral and gingival health research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers), Stroke Rehabilitation and Recovery (2 papers), Cardiac Imaging and Diagnostics (2 papers), Cardiac Structural Anomalies and Repair (2 papers), Pancreatic and Hepatic Oncology Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Immunology (97 citations), Immunology and Allergy (26 citations) and Nephrology (26 citations). Makoto Ueno has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Hiroaki Sakurai, Takahisa Sugita, Masaki Sugiura, Yutaka Hisada, Isao Takata, Kazunori Imaizumi, Satoshi Kobayashi, Taito Fukushima, H. Nagai and Kousaku Ohno. Their work appears in journals such as Journal of Clinical Oncology, Journal of Neuroscience and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.